HEART TEST LABORATORIES INC's ticker is and the CUSIP is 42254E104. A total of 11 filers reported holding HEART TEST LABORATORIES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,653 | -71.0% | 69,607 | -38.3% | 0.01% | -67.6% |
| Q2 2023 | $102,133 | -33.9% | 112,854 | -27.9% | 0.04% | -43.9% |
| Q1 2023 | $154,594 | +13.7% | 156,630 | -3.2% | 0.07% | -14.3% |
| Q4 2022 | $135,932 | +353.1% | 161,844 | +547.4% | 0.08% | +305.3% |
| Q3 2022 | $30,000 | – | 25,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OLIVER LAGORE VANVALIN INVESTMENT GROUP | 156,630 | $154,594 | 0.07% |
| CHAPIN DAVIS, INC. | 55,000 | $54,285 | 0.03% |
| Tradition Wealth Management, LLC | 87,501 | $86 | 0.01% |
| AE Wealth Management LLC | 149,490 | $147,547 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 11,263 | $11,117 | 0.00% |
| Tower Research Capital LLC (TRC) | 2,472 | $2 | 0.00% |
| Renaissance Technologies | 22,700 | $22 | 0.00% |
| ROYAL BANK OF CANADA | 85,980 | $85,000 | 0.00% |
| UBS Group AG | 1,109 | $1,095 | 0.00% |